xuliang
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Real-World Study of Inavolisib in Patients With HR-Positive/HER2-Negative, PIK3CA-Mutated Advanced Breast Cancer (NCT07543250) | xuliang | 2026-05-16 |
Track xuliang automatically
Every clearance here is in the API, with alerts when new ones post.